Sanofi still beating drum on pipeline progress in latest showcase

24 June 2020
paul_hudson_sanofi_large

French drugmaker Sanofi (Euronext: SAN) has certainly been on a public relations drive this year, using every chance possible to show off the progress of its pipeline and its investments in innovation and manufacturing.

Sanofi has now held the fourth of a five-part series highlighting how the company is leading with innovation, with Tuesday’s event labelled its Virtual R&D Day.

Focus on first-in-class medicines

This article is accessible to registered users, to continue reading please register for free.  A free trial will give you access to exclusive features, interviews, round-ups and commentary from the sharpest minds in the pharmaceutical and biotechnology space for a week. If you are already a registered user please login. If your trial has come to an end, you can subscribe here.

Login to your account

Become a subscriber

 

£820

Or £77 per month

Subscribe Now
  • Unfettered access to industry-leading news, commentary and analysis in pharma and biotech.
  • Updates from clinical trials, conferences, M&A, licensing, financing, regulation, patents & legal, executive appointments, commercial strategy and financial results.
  • Daily roundup of key events in pharma and biotech.
  • Monthly in-depth briefings on Boardroom appointments and M&A news.
  • Choose from a cost-effective annual package or a flexible monthly subscription
The Pharma Letter is an extremely useful and valuable Life Sciences service that brings together a daily update on performance people and products. It’s part of the key information for keeping me informed

Chairman, Sanofi Aventis UK

Companies featured in this story

More ones to watch >


Today's issue

Company Spotlight





More Features in Pharmaceutical